Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Jouinot

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
Thyroid : Official Journal of the American Thyroid Association|September 17, 2024
Consideration of Early Dynamic Risk Stratification to Guide Discharge from Oncologic Follow-Up in Patients with Differentiated Thyroid CancerAmina Attia, Eliane Touma, Charlotte Lussey-Lepoutre, et al.
Thyroid : Official Journal of the American Thyroid Association|December 21, 2019
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION TrialOlivier Huillard, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Radiology|May 10, 2026
A CT-based deep learning model to differentiate between benign and malignant adrenal lesionsZack Huang, Anthony Dohan, Guillaume Assié, et al.
Annals of Nutrition & Metabolism|December 23, 2019
Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung CancerGuillaume Ulmann, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Endocrinology|October 4, 2021
Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort studyBertrand Baussart, Chiara Villa, Anne Jouinot, et al.
Frontiers in Endocrinology|September 15, 2022
Outcome of giant pituitary tumors requiring surgeryStephan Gaillard, Sosthène Adeniran, Chiara Villa, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Endocrine-Related Cancer|June 1, 2021
Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumorsMarc Diedisheim, Solène Dermine, Anne Jouinot, et al.
Cancers|February 15, 2022
Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the ArtMaxime Barat, Anne-Ségolène Cottereau, Sébastien Gaujoux, et al.
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
Thyroid : Official Journal of the American Thyroid Association|September 17, 2024
Consideration of Early Dynamic Risk Stratification to Guide Discharge from Oncologic Follow-Up in Patients with Differentiated Thyroid CancerAmina Attia, Eliane Touma, Charlotte Lussey-Lepoutre, et al.
Thyroid : Official Journal of the American Thyroid Association|December 21, 2019
Body Composition in Patients with Radioactive Iodine-Refractory, Advanced Differentiated Thyroid Cancer Treated with Sorafenib or Placebo: A Retrospective Analysis of the Phase III DECISION TrialOlivier Huillard, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Radiology|May 10, 2026
A CT-based deep learning model to differentiate between benign and malignant adrenal lesionsZack Huang, Anthony Dohan, Guillaume Assié, et al.
Annals of Nutrition & Metabolism|December 23, 2019
Lean Body Mass and Endocrine Status But Not Age Are Determinants of Resting Energy Expenditure in Patients with Non-Small Cell Lung CancerGuillaume Ulmann, Anne Jouinot, Camille Tlemsani, et al.
European Journal of Endocrinology|October 4, 2021
Pituitary surgery as alternative to dopamine agonists treatment for microprolactinomas: a cohort studyBertrand Baussart, Chiara Villa, Anne Jouinot, et al.
Frontiers in Endocrinology|September 15, 2022
Outcome of giant pituitary tumors requiring surgeryStephan Gaillard, Sosthène Adeniran, Chiara Villa, et al.
European Journal of Clinical Pharmacology|March 23, 2023
Predictive factors associated with pemetrexed acute toxicityMathilde Bonnet, Anne Jouinot, Pascaline Boudou-Rouquette, et al.
Endocrine-Related Cancer|June 1, 2021
Prognostic transcriptome classes of duodenopancreatic neuroendocrine tumorsMarc Diedisheim, Solène Dermine, Anne Jouinot, et al.
Cancers|February 15, 2022
Adrenal Mass Characterization in the Era of Quantitative Imaging: State of the ArtMaxime Barat, Anne-Ségolène Cottereau, Sébastien Gaujoux, et al.
European Journal of Human Genetics : EJHG|May 6, 2025
Predisposition to prostate cancer and clinical implications in a real-life cohortJulie Chartier, Albain Chansavang, Anne Jouinot, et al.
Pageof 9